GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $593,000 | -46.3% | 123,272 | -32.4% | 0.02% | -40.7% |
| Q3 2019 | $1,105,000 | -31.4% | 182,387 | -26.5% | 0.03% | -22.9% |
| Q2 2019 | $1,610,000 | -32.2% | 248,099 | -26.0% | 0.04% | -32.7% |
| Q1 2019 | $2,376,000 | +489.6% | 335,106 | +304.1% | 0.05% | +420.0% |
| Q4 2018 | $403,000 | -71.3% | 82,926 | -30.4% | 0.01% | -76.7% |
| Q3 2016 | $1,405,000 | +26.5% | 119,066 | +10.8% | 0.04% | +43.3% |
| Q2 2013 | $1,111,000 | – | 107,453 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |